Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 10903395)

1.

Baths salts, spice, and related designer drugs: the science behind the headlines.

Baumann MH, Solis E Jr, Watterson LR, Marusich JA, Fantegrossi WE, Wiley JL.

J Neurosci. 2014 Nov 12;34(46):15150-8. doi: 10.1523/JNEUROSCI.3223-14.2014. Review.

PMID:
25392483
2.

Cross-substitution of Δ9-tetrahydrocannabinol and JWH-018 in drug discrimination in rats.

Wiley JL, Lefever TW, Cortes RA, Marusich JA.

Pharmacol Biochem Behav. 2014 Sep;124:123-8. doi: 10.1016/j.pbb.2014.05.016. Epub 2014 Jun 2.

PMID:
24887450
3.

Novel adamantyl cannabinoids as CB1 receptor probes.

Thakur GA, Bajaj S, Paronis C, Peng Y, Bowman AL, Barak LS, Caron MG, Parrish D, Deschamps JR, Makriyannis A.

J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14.

4.

Hijacking of Basic Research: The Case of Synthetic Cannabinoids.

Wiley JL, Marusich JA, Huffman JW, Balster RL, Thomas BF.

Methods Rep RTI Press. 2011 Nov;2011. pii: 17971.

5.

LiCABEDS II. Modeling of ligand selectivity for G-protein-coupled cannabinoid receptors.

Ma C, Wang L, Yang P, Myint KZ, Xie XQ.

J Chem Inf Model. 2013 Jan 28;53(1):11-26. doi: 10.1021/ci3003914. Epub 2013 Jan 15.

6.

The CB2-preferring agonist JWH015 also potently and efficaciously activates CB1 in autaptic hippocampal neurons.

Murataeva N, Mackie K, Straiker A.

Pharmacol Res. 2012 Nov;66(5):437-42. doi: 10.1016/j.phrs.2012.08.002. Epub 2012 Aug 14.

7.

Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.

Turkman N, Shavrin A, Paolillo V, Yeh HH, Flores L, Soghomonian S, Rabinovich B, Volgin A, Gelovani J, Alauddin M.

Nucl Med Biol. 2012 May;39(4):593-600. doi: 10.1016/j.nucmedbio.2011.10.019. Epub 2012 Jan 4.

8.

Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice.

Willecke F, Zeschky K, Ortiz Rodriguez A, Colberg C, Auwärter V, Kneisel S, Hutter M, Lozhkin A, Hoppe N, Wolf D, von zur Mühlen C, Moser M, Hilgendorf I, Bode C, Zirlik A.

PLoS One. 2011 Apr 26;6(4):e19405. doi: 10.1371/journal.pone.0019405.

9.

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.

Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K.

Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2699-704. doi: 10.1073/pnas.0711278105. Epub 2008 Feb 8.

10.

Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.

Guindon J, Hohmann AG.

Br J Pharmacol. 2008 Jan;153(2):319-34. Epub 2007 Nov 12. Review.

11.

Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.

Huffman JW, Thompson AL, Wiley JL, Martin BR.

Bioorg Med Chem. 2008 Jan 1;16(1):322-35. Epub 2007 Sep 22.

12.

Endocannabinoids protect the rat isolated heart against ischaemia.

Lépicier P, Bouchard JF, Lagneux C, Lamontagne D.

Br J Pharmacol. 2003 Jun;139(4):805-15.

13.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk